GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each hard gelatin capsule contains:
Aspirin USP…………………25mg
(Immediate- release Tablet)
Dipyridamole USP……….200mg
(As extended releasepellets)
Excipients…………………q.s.
Approved colours used in capsule shells.
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Protect from light and moisture.
Dosage: As directed by the Physician
Attach dispensing label as per end country.
Aspirin Extended Release Dipyridamole Capsules 25mg+200mg Technical Specification:
| Product Name: | Aspirin and Extended-Release Dipyridamole Capsules |
| Brand Name: | Generic |
| Strength: | 25mg+200mg |
| Dosage Form: | Capsules (Hard gelatin) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anticoagulant |
| Indication: | Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. |
| Storage: | Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
1. Aspirin Extended Release Dipyridamole Capsules 25mg+200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
1. Aspirin Extended Release Dipyridamole Capsules 25mg+200mg
Each hard gelatin capsule contains:
Aspirin USP…………………25mg
(Immediate- release Tablet)
Dipyridamole USP……….200mg
(As extended releasepellets)
Excipients…………………q.s.
Approved colours used in capsule shells.
THERAPEUTIC INDICATIONS:
Aspirin and Extended-Release Dipyridamole Capsule is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis.
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
STORAGE & DOSAGE:
Storage: Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Protect from light and moisture.
Dosage: As directed by the Physician
Attach dispensing label as per end country.
.
Introduction to Aspirin Extended Release Dipyridamole Capsules 25mg+200mg
Aspirin Extended Release Dipyridamole Capsules 25mg+200mg are a clinically proven antiplatelet combination medicine widely prescribed for the prevention of recurrent strokes and transient ischemic attacks (TIA). This dual-drug formulation combines Aspirin, which inhibits platelet aggregation by blocking thromboxane A2, and Dipyridamole (Extended Release), which enhances blood flow by inhibiting platelet activation and improving cerebral circulation.
Globally, the demand for Aspirin Extended Release Dipyridamole Capsules 25mg+200mg is increasing due to the rising incidence of cardiovascular and cerebrovascular diseases, aging populations, and improved diagnosis of stroke risk. Hospitals, government tenders, and private healthcare providers across Asia, Africa, Latin America, CIS, and the Middle East actively source this medicine from reliable manufacturers.
As a result, choosing a WHO-GMP certified Aspirin Extended Release Dipyridamole Capsules 25mg+200mg manufacturer in India is critical for importers and distributors. Taj Pharma Ltd, based in Vapi, Gujarat, stands out as a trusted global supplier offering consistent quality, regulatory compliance, and export excellence.
About Aspirin Extended Release Dipyridamole Capsules 25mg+200mg
Aspirin Extended Release Dipyridamole Capsules 25mg+200mg are indicated for patients who have already experienced a stroke or mini-stroke (TIA) and are at risk of developing blood clots. The medicine works by preventing platelets from sticking together, thereby reducing the formation of harmful clots that can block blood flow to the brain.
Therapeutic Uses
-
Prevention of recurrent ischemic stroke
-
Prevention of transient ischemic attacks (TIA)
-
Long-term antiplatelet therapy in high-risk patients
Mechanism of Action
This combination medicine:
-
Reduces platelet aggregation
-
Improves cerebral blood circulation
-
Lowers the risk of clot-related complications
Common Side Effects
-
Headache
-
Diarrhea
-
Nausea and dyspepsia
-
Abdominal pain
-
Worsening of coronary artery disease symptoms
Patients are advised to inform their doctor if they experience persistent stomach pain, vomiting, or notice blood in stool or urine.
Trusted Aspirin Extended Release Dipyridamole Capsules 25mg+200mg Manufacturer in India
Taj Pharma Ltd is a well-established Manufacturer, Exporter, and Supplier of Aspirin Extended Release Dipyridamole Capsules 25mg+200mg from Vapi, Gujarat, India. With decades of pharmaceutical manufacturing expertise, Taj Pharma delivers world-class formulations that meet international quality and safety standards.
As a PAN India manufacturer, Taj Pharma supplies to Mumbai, Maharashtra, and all major Indian pharmaceutical hubs while maintaining a strong global export presence.
In-Depth Details for Importers, Exporters & Global Buyers
Regulatory Documentation Provided
Taj Pharma supports global partners with complete regulatory assistance, including:
-
Certificate of Pharmaceutical Product (COPP)
-
WHO-GMP Certification
-
EU-GMP support dossiers
-
CTD / eCTD Dossiers
-
Stability Data
-
MSDS & COA
-
Batch Manufacturing Records (BMR)
Custom Packaging & Labeling
-
Blister packs / HDPE bottles
-
Buyer-specific artwork and branding
-
Multilingual labeling as per importing country norms
-
Compliance with FDA, MOH, and local authority requirements
Shelf-Life, Storage & Dosage Form
-
Dosage Form: Extended Release Capsules
-
Shelf Life: 24–36 months
-
Storage: Store below 25°C, protected from moisture and light
Export Certifications
-
WHO-GMP Manufacturer India
-
ISO Certified Facilities
-
GDP-Compliant Logistics
-
Export-ready documentation for regulated & semi-regulated markets
Target Export Countries & Markets
-
Africa
-
Middle East
-
Southeast Asia
-
CIS Countries
-
Latin America
-
Europe (Dossier support basis)
Why Taj Pharma Is the Most Trusted Manufacturer & Exporter
State-of-the-Art Manufacturing
Taj Pharma operates advanced WHO-GMP compliant manufacturing facilities equipped with:
-
Automated production lines
-
In-house quality control laboratories
-
Stringent process validation systems
Affordable Pricing & Quality Assurance
-
Competitive export pricing
-
Zero-compromise quality policy
-
Batch-to-batch consistency
Global Presence & Supply Chain Support
-
Strong logistics network
-
Timely dispatch & export handling
-
Dedicated export documentation team
Top 20 Countries Exporting
India , Bangladesh, Nepal, Sri Lanka, Vietnam, Philippines, Cambodia, Nigeria, Kenya, Ghana, Egypt, Ethiopia, Morocco, Peru, Colombia, Ecuador, Bolivia , Ukraine, Uzbekistan, Kazakhstan
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Aspirin Extended Release Dipyridamole Capsules |
| Strength | 25mg + 200mg |
| Dosage Form | Extended Release Capsules |
| Therapeutic Class | Antiplatelet |
| Packaging | Blister / Bottle |
| Shelf Life | 24–36 Months |
| Storage | Below 25°C |
| Manufacturer | Taj Pharma Ltd |
| Manufacturing Location | Vapi, Gujarat, India |
| Certifications | WHO-GMP, ISO |
| Export Markets | Global |
Call to Action
If you are searching for a Leading Aspirin Extended Release Dipyridamole Capsules 25mg+200mg Manufacturer & Supplier in India, Taj Pharma Ltd is your trusted partner. We offer PCD Pharma Franchise, bulk supply, contract manufacturing, and export support tailored to your market needs.
📩 Contact Taj Pharma today to request pricing, dossiers, samples, or partnership opportunities.
Top 20 FAQs
-
What is Aspirin Extended Release Dipyridamole Capsules used for?
Used to prevent recurrent strokes and TIAs. -
Is Taj Pharma WHO-GMP certified?
Yes, Taj Pharma is a WHO-GMP certified manufacturer. -
Can this product be exported globally?
Yes, with full export documentation. -
Is PCD Pharma Franchise available?
Yes, PAN India PCD Pharma Franchise is available. -
What is the shelf life?
24–36 months. -
Can packaging be customized?
Yes, buyer-specific packaging is available. -
Is this medicine safe for long-term use?
Yes, under medical supervision. -
Does Taj Pharma provide CTD dossiers?
Yes. -
What are the common side effects?
Headache, nausea, dyspepsia, diarrhea. -
Is it available in Mumbai?
Yes, supplied across Mumbai and Maharashtra. -
What is the storage condition?
Store below 25°C. -
Is bulk supply available?
Yes. -
Is this product export-ready?
Absolutely. -
Does Taj Pharma support regulatory filings?
Yes. -
Is Dipyridamole extended release?
Yes. -
What certifications are available?
WHO-GMP, ISO, COPP. -
Which countries import from Taj Pharma?
Over 20 countries worldwide. -
Is third-party manufacturing available?
Yes. -
How to place an order?
Contact Taj Pharma export team. -
Why choose Taj Pharma?
Quality, trust, compliance, and global reach.






